単一ドメイン抗体プラットフォームに関する市場調査。治療薬開発への高い応用が見込まれる

Market Study on Single Domain Antibody Platforms: High Application in Therapeutic Development to Be Witnessed

シングルドメインアンチボディプラットフォームの市場 - レポートの範囲 Persistence Market Research社が発行した世界の単一ドメイン抗体プラットフォーム市場に関する最新刊は、機会や現在の市場展望を評価... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Persistence Market Research パーシスタンスマーケットリサーチ	2022年8月2日	US$4,900 シングルユーザライセンスライセンス・価格情報注文方法はこちら	291	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

シングルドメインアンチボディプラットフォームの市場 - レポートの範囲

Persistence Market Research社が発行した世界の単一ドメイン抗体プラットフォーム市場に関する最新刊は、機会や現在の市場展望を評価し、市場に影響を与える対応するセクションに関する詳細な分析と最新情報を提供しています。この調査は、市場の促進要因、抑制要因、動向、機会などを含む現在の市場力学に関する詳細な洞察を提供します。市場調査の主な目的は、2022年から2032年の予測期間中に市場がどのように推移するかについての独占情報を提示することです。

市場の成功成長のための重要な指標は、この包括的なレポートで提示されており、市場の前年比（YoY）成長分析、複合年間成長率（CAGR）など、Persistence Market Research社の調査において網羅的に記述されています。この調査研究は、単一ドメイン抗体の需要や調査期間中の定量的な開発機会を知る上で読者をサポートすることができます。

この調査は、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーなどの景観の株主にとって有益であり、単一ドメイン抗体プラットフォーム市場で繁栄するために適切なビジネス戦略を開発するのに役立ちます。この持続性市場調査で提示された洞察と情報は、単一ドメイン抗体プラットフォーム市場の株主、業界専門家、投資家、研究者、記者、ビジネス愛好家が活用することができます。

市場統計、および単一ドメイン抗体プラットフォーム市場のビジネスシナリオに影響を与えるマクロ経済変数だけでなくミクロ経済変数に関連する情報も、現在の調査に含まれています。市場の潜在的な発展に応じて、実質的な洞察も本レポートで遭遇します。さらに、このレポートで提出されたデータによって、業界のマイナーな企業や新規参入者は、市場での牽引力を得るために適切な企業選択をする際に支援されることができます。

主要な市場セグメント

Persistence Market Research社の単一ドメイン抗体プラットフォーム市場に関する調査では、プラットフォームタイプ、動物由来、アプリケーション、エンドユーザー、地域という5つの重要なセグメントに分けられた情報を提供しています。本レポートは、これらのカテゴリに関連する重要な市場力学と成長パラメータに関する包括的なデータと情報を提供します。

プラットフォームタイプ

多特異的単一ドメイン抗体
バイスペシフィック単一ドメイン抗体
多価単一ドメイン抗体
単特異性単一ドメイン抗体
動物由来

ラクダ科動物
ラクダ
ラマ
アルパカ
サメ
アプリケーション

診断薬開発
治療薬開発
研究・開発活動
エンドユーザー

診断ラボラトリー
臨床検査機関
学術・研究機関
製薬会社・バイオテクノロジー企業
地域別

北アメリカ
ラテンアメリカ
欧州
南アジア
東アジア
オセアニア
中東・アフリカ（MEA）
報告書に記載されている主な質問

今後数年間、単一ドメイン抗体で最も収益性の高い市場を維持し続けるのはどの地域か？
トレンドの変化は市場にどのような影響を与えるのか？
COVID-19危機は市場の成長にどのような影響を与えたか？
市場参加者はどのようにして先進地域の低空飛行の機会を捕らえることができるのか？
市場におけるステークホルダーの戦略はどのようなものですか？
投資家が認識する必要があり、市場への投資中に取り組む可能性がある抑制要因は何か？
市場に影響を与えるであろう開発動向は何か？
単一ドメイン抗体プラットフォーム市場の企業は、先進国および新興国での成長機会をどのように利用することができますか？
調査方法

Persistence Market Research社の調査では、単一ドメイン抗体プラットフォーム市場の成長に関する広範な調査を実施し、市場の将来の成長パラメータに関する結論に到達するために、独自の調査手法を活用しています。この調査手法は、一次調査と二次調査を組み合わせたもので、アナリストが結論の正確性と信頼性を確保するのに役立ちます。

市場調査作成時にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは一次資料として、本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行いました。

一次および二次リソースから取得した包括的な情報は、市場の企業からの検証として機能し、単一ドメイン抗体プラットフォーム市場の成長見通しに関するPersistence Market Researchの予測をより正確かつ信頼性の高いものにしています。

ページTOPに戻る

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Form Innovation / Development Trends

4. Key Inclusions

4.1. Product Adoption Rate/Usage Analysis- Key Statistics

4.2. Key Promotional Strategies, By Key Manufacturers

4.3. Technology Advancement

4.4. Key Regulations, By Region

4.5. PESTLE Analysis

4.6. Value Chain Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

5.1.2. Global Healthcare Industry Market Outlook

5.1.3. Global Life Science Market Outlook

5.2. Forecast Factors - Relevance & Impact

5.2.1. Key Player’s Historical Growth

5.2.2. Increasing Research and Development Activities

5.2.3. Market Consolidation Activities

5.2.4. New Products Launches

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. Current COVID-19 Statistics and Probable Future Impact

6.2. Current GDP Projection and Probable Impact

6.3. Current Economic Projection as compared to 2008 Economic analysis

6.4. COVID19 and Impact Analysis

6.4.1. By Platform Type

6.4.2. By Country

6.5. 2020 Market Scenario

6.6. Recovery Scenario – Short-Term, Midterm, and Long-Term Impact

7. Global Single Domain Antibody Platform Market Demand (in Value or Size in US$ Mn) Analysis 2015–2021 and Forecast, 2022–2032

7.1. Historical Market Value (US$ Mn) Analysis, 2015–2021

7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Single Domain Antibody Platform Market Analysis 2015–2021 and Forecast 2022–2032, By Platform Type

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Platform Type, 2015–2021

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Platform Type, 2022–2032

8.3.1. Multi-specific Single Domain Antibody

8.3.2. Multi-specific Single Domain Antibody

8.3.3. Multivalent Single Domain Antibody

8.3.4. Mono-specific Single Domain Antibody

8.4. Market Attractiveness Analysis By Platform Type

9. Global Single Domain Antibody Platform Market Analysis 2015–2021 and Forecast 2022–2032, By Animal Source

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By Animal Source, 2015–2021

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Animal Source, 2022–2032

9.3.1. Camelids

9.3.1.1. Camels

9.3.1.2. Llama

9.3.1.3. Alpacas

9.3.2. Shark

9.4. Market Attractiveness Analysis By Animal Source

10. Global Single Domain Antibody Platform Market Analysis 2015–2021 and Forecast 2022–2032, By Application

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Application, 2015–2021

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022–2032

10.3.1. Diagnostic Development

10.3.2. Therapeutic Development

10.3.3. Research & Developmental Activities

10.4. Market Attractiveness Analysis By Application

11. Global Single Domain Antibody Platform Market Analysis 2015–2021 and Forecast 2022–2032, By End User

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2021

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032

11.3.1. Diagnostic Laboratories

11.3.2. Clinical Laboratories

11.3.3. Academic & Research Institutes

11.3.4. Pharmaceutical & Biotechnology Companies

11.4. Market Attractiveness Analysis By End User

12. Single Domain Antibody Platform Market Analysis 2015–2021 and Forecast 2022–2032, By Region

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2021

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032

12.3.1. North America

12.3.2. Latin America

12.3.3. Europe

12.3.4. South Asia

12.3.5. East Asia

12.3.6. Oceania

12.3.7. Middle East and Africa

12.4. Market Attractiveness Analysis By Region

13. North America Single Domain Antibody Platform Market Analysis 2015–2021 and Forecast 2022–2032

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

13.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032

13.3.1. By Country

13.3.1.1. U.S.

13.3.1.2. Canada

13.3.2. By Platform Type

13.3.3. By Animal Source

13.3.4. By Application

13.3.5. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Platform Type

13.4.3. By Animal Source

13.4.4. By Application

13.4.5. By End User

13.5. Key Market Participants - Intensity Mapping

13.6. Drivers and Restraints - Impact Analysis

13.7. Country Level Analysis & Forecast

13.7.1. U.S. Single Domain Antibody Platform Market

13.7.1.1. Introduction

13.7.1.2. Market Analysis and Forecast by Market Taxonomy

13.7.1.2.1. By Platform Type

13.7.1.2.2. By Animal Source

13.7.1.2.3. By Application

13.7.1.2.4. By End User

13.7.2. Canada Single Domain Antibody Platform Market

13.7.2.1. Introduction

13.7.2.2. Market Analysis and Forecast by Market Taxonomy

13.7.2.2.1. By Platform Type

13.7.2.2.2. By Animal Source

13.7.2.2.3. By Application

13.7.2.2.4. By End User

14. Latin America Single Domain Antibody Platform Market Analysis 2015–2021 and Forecast 2022–2032

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

14.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032

14.3.1. By Country

14.3.1.1. Brazil

14.3.1.2. Mexico

14.3.1.3. Rest of Latin America

14.3.2. By Platform Type

14.3.3. By Animal Source

14.3.4. By Application

14.3.5. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Platform Type

14.4.3. By Animal Source

14.4.4. By Application

14.4.5. By End User

14.5. Key Market Participants - Intensity Mapping

14.6. Drivers and Restraints - Impact Analysis

14.7. Country Level Analysis & Forecast

14.7.1. Brazil Single Domain Antibody Platform Market

14.7.1.1. Introduction

14.7.1.2. Market Analysis and Forecast by Market Taxonomy

14.7.1.2.1. By Platform Type

14.7.1.2.2. By Animal Source

14.7.1.2.3. By Application

14.7.1.2.4. By End User

14.7.2. Argentina Single Domain Antibody Platform Market

14.7.2.1. Introduction

14.7.2.2. Market Analysis and Forecast by Market Taxonomy

14.7.2.2.1. By Platform Type

14.7.2.2.2. By Animal Source

14.7.2.2.3. By Application

14.7.2.2.4. By End User

14.7.3. Mexico Single Domain Antibody Platform Market

14.7.3.1. Introduction

14.7.3.2. Market Analysis and Forecast by Market Taxonomy

14.7.3.2.1. By Platform Type

14.7.3.2.2. By Animal Source

14.7.3.2.3. By Application

14.7.3.2.4. By End User

15. Europe Single Domain Antibody Platform Market Analysis 2015–2021 and Forecast 2022–2032

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

15.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032

15.3.1. By Country

15.3.1.1. Germany

15.3.1.2. Italy

15.3.1.3. France

15.3.1.4. U.K.

15.3.1.5. Spain

15.3.1.6. BENELUX

15.3.1.7. Russia

15.3.1.8. Rest of Europe

15.3.2. By Platform Type

15.3.3. By Animal Source

15.3.4. By Application

15.3.5. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Platform Type

15.4.3. By Animal Source

15.4.4. By Application

15.4.5. By End User

15.5. Key Market Participants - Intensity Mapping

15.6. Drivers and Restraints - Impact Analysis

15.7. Country Level Analysis & Forecast

15.7.1. Germany Single Domain Antibody Platform Market

15.7.1.1. Introduction

15.7.1.2. Market Analysis and Forecast by Market Taxonomy

15.7.1.2.1. By Platform Type

15.7.1.2.2. By Animal Source

15.7.1.2.3. By Application

15.7.1.2.4. By End User

15.7.2. France Single Domain Antibody Platform Market

15.7.2.1. Introduction

15.7.2.2. Market Analysis and Forecast by Market Taxonomy

15.7.2.2.1. By Platform Type

15.7.2.2.2. By Animal Source

15.7.2.2.3. By Application

15.7.2.2.4. By End User

15.7.3. Italy Single Domain Antibody Platform Market

15.7.3.1. Introduction

15.7.3.2. Market Analysis and Forecast by Market Taxonomy

15.7.3.2.1. By Platform Type

15.7.3.2.2. By Animal Source

15.7.3.2.3. By Application

15.7.3.2.4. By End User

15.7.4. Spain Single Domain Antibody Platform Market

15.7.4.1. Introduction

15.7.4.2. Market Analysis and Forecast by Market Taxonomy

15.7.4.2.1. By Platform Type

15.7.4.2.2. By Animal Source

15.7.4.2.3. By Application

15.7.4.2.4. By End User

15.7.5. U.K. Single Domain Antibody Platform Market

15.7.5.1. Introduction

15.7.5.2. Market Analysis and Forecast by Market Taxonomy

15.7.5.2.1. By Platform Type

15.7.5.2.2. By Animal Source

15.7.5.2.3. By Application

15.7.5.2.4. By End User

15.7.6. Benelux Union Single Domain Antibody Platform Market

15.7.6.1. Introduction

15.7.6.2. Market Analysis and Forecast by Market Taxonomy

15.7.6.2.1. By Platform Type

15.7.6.2.2. By Animal Source

15.7.6.2.3. By Application

15.7.6.2.4. By End User

15.7.7. Russia Single Domain Antibody Platform Market

15.7.7.1. Introduction

15.7.7.2. Market Analysis and Forecast by Market Taxonomy

15.7.7.2.1. By Platform Type

15.7.7.2.2. By Animal Source

15.7.7.2.3. By Application

15.7.7.2.4. By End User

16. South Asia Single Domain Antibody Platform Market Analysis 2015–2021 and Forecast 2022–2032

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

16.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032

16.3.1. By Country

16.3.1.1. India

16.3.1.2. Thailand

16.3.1.3. Indonesia

16.3.1.4. Malaysia

16.3.1.5. Rest of South Asia

16.3.2. By Platform Type

16.3.3. By Animal Source

16.3.4. By Application

16.3.5. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Platform Type

16.4.3. By Animal Source

16.4.4. By Application

16.4.5. By End User

16.5. Key Market Participants - Intensity Mapping

16.6. Drivers and Restraints - Impact Analysis

16.7. Country Level Analysis & Forecast

16.7.1. India Single Domain Antibody Platform Market

16.7.1.1. Introduction

16.7.1.2. Market Analysis and Forecast by Market Taxonomy

16.7.1.2.1. By Platform Type

16.7.1.2.2. By Animal Source

16.7.1.2.3. By Application

16.7.1.2.4. By End User

16.7.2. Indonesia Single Domain Antibody Platform Market

16.7.2.1. Introduction

16.7.2.2. Market Analysis and Forecast by Market Taxonomy

16.7.2.2.1. By Platform Type

16.7.2.2.2. By Animal Source

16.7.2.2.3. By Application

16.7.2.2.4. By End User

16.7.3. Malaysia Single Domain Antibody Platform Market

16.7.3.1. Introduction

16.7.3.2. Market Analysis and Forecast by Market Taxonomy

16.7.3.2.1. By Platform Type

16.7.3.2.2. By Animal Source

16.7.3.2.3. By Application

16.7.3.2.4. By End User

16.7.4. Thailand Single Domain Antibody Platform Market

16.7.4.1. Introduction

16.7.4.2. Market Analysis and Forecast by Market Taxonomy

16.7.4.2.1. By Platform Type

16.7.4.2.2. By Animal Source

16.7.4.2.3. By Application

16.7.4.2.4. By End User

17. East Asia Single Domain Antibody Platform Market Analysis 2015–2021 and Forecast 2022–2032

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

17.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032

17.3.1. By Country

17.3.1.1. China

17.3.1.2. Japan

17.3.1.3. South Korea

17.3.2. By Platform Type

17.3.3. By Animal Source

17.3.4. By Application

17.3.5. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Platform Type

17.4.3. By Animal Source

17.4.4. By Application

17.4.5. By End User

17.5. Key Market Participants - Intensity Mapping

17.6. Drivers and Restraints - Impact Analysis

17.7. Country Level Analysis & Forecast

17.7.1. China Single Domain Antibody Platform Market

17.7.1.1. Introduction

17.7.1.2. Market Analysis and Forecast by Market Taxonomy

17.7.1.2.1. By Platform Type

17.7.1.2.2. By Animal Source

17.7.1.2.3. By Application

17.7.1.2.4. By End User

17.7.2. Japan Single Domain Antibody Platform Market

17.7.2.1. Introduction

17.7.2.2. Market Analysis and Forecast by Market Taxonomy

17.7.2.2.1. By Platform Type

17.7.2.2.2. By Animal Source

17.7.2.2.3. By Application

17.7.2.2.4. By End User

17.7.3. South Korea Single Domain Antibody Platform Market

17.7.3.1. Introduction

17.7.3.2. Market Analysis and Forecast by Market Taxonomy

17.7.3.2.1. By Platform Type

17.7.3.2.2. By Animal Source

17.7.3.2.3. By Application

17.7.3.2.4. By End User

18. Oceania Single Domain Antibody Platform Market Analysis 2015–2021 and Forecast 2022–2032

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

18.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032

18.3.1. By Country

18.3.1.1. Australia

18.3.1.2. New Zealand

18.3.2. By Platform Type

18.3.3. By Animal Source

18.3.4. By Application

18.3.5. By End User

18.4. Market Attractiveness Analysis

18.4.1. By Country

18.4.2. By Platform Type

18.4.3. By Animal Source

18.4.4. By Application

18.4.5. By End User

18.5. Key Market Participants - Intensity Mapping

18.6. Drivers and Restraints - Impact Analysis

18.6.1. By Country

18.6.2. By Platform Type

18.6.3. By Animal Source

18.6.4. By Application

18.6.5. By End User

18.7. Country Level Analysis & Forecast

18.7.1. Australia Single Domain Antibody Platform Market

18.7.1.1. Introduction

18.7.1.2. Market Analysis and Forecast by Market Taxonomy

18.7.1.2.1. By Platform Type

18.7.1.2.2. By Animal Source

18.7.1.2.3. By Application

18.7.1.2.4. By End User

18.7.2. New Zealand Single Domain Antibody Platform Market

18.7.2.1. Introduction

18.7.2.2. Market Analysis and Forecast by Market Taxonomy

18.7.2.2.1. By Platform Type

18.7.2.2.2. By Animal Source

18.7.2.2.3. By Application

18.7.2.2.4. By End User

19. Middle East and Africa (MEA) Single Domain Antibody Platform Market Analysis 2015–2021 and Forecast 2022–2032

19.1. Introduction

19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2021

19.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032

19.3.1. By Country

19.3.1.1. GCC Countries

19.3.1.2. Turkey

19.3.1.3. South Africa

19.3.1.4. Rest of Middle East and Africa

19.3.2. By Platform Type

19.3.3. By Animal Source

19.3.4. By Application

19.3.5. By End User

19.4. Market Attractiveness Analysis

19.4.1. By Country

19.4.2. By Platform Type

19.4.3. By Animal Source

19.4.4. By Application

19.4.5. By End User

19.5. Key Market Participants - Intensity Mapping

19.6. Drivers and Restraints - Impact Analysis

19.6.1. By Country

19.6.2. By Platform Type

19.6.3. By Animal Source

19.6.4. By Application

19.6.5. By End User

19.7. Country Level Analysis & Forecast

19.7.1. GCC Countries Single Domain Antibody Platform Market

19.7.1.1. Introduction

19.7.1.2. Market Analysis and Forecast by Market Taxonomy

19.7.1.2.1. By Platform Type

19.7.1.2.2. By Animal Source

19.7.1.2.3. By Application

19.7.1.2.4. By End User

19.7.2. Turkey Single Domain Antibody Platform Market

19.7.2.1. Introduction

19.7.2.2. Market Analysis and Forecast by Market Taxonomy

19.7.2.2.1. By Platform Type

19.7.2.2.2. By Animal Source

19.7.2.2.3. By Application

19.7.2.2.4. By End User

19.7.3. South Africa Single Domain Antibody Platform Market

19.7.3.1. Introduction

19.7.3.2. Market Analysis and Forecast by Market Taxonomy

19.7.3.2.1. By Platform Type

19.7.3.2.2. By Animal Source

19.7.3.2.3. By Application

19.7.3.2.4. By End User

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies

20.2. Market Share Analysis of Top Players

20.3. Market Presence Analysis

20.3.1. Regional footprint of Players

20.3.2. Platform Type footprint by Players

20.3.3. Channel Foot Print by Players

21. Competition Analysis

21.1. Competition Dashboard

21.2. Competition Benchmarking

21.3. Competition Deep Dive

21.3.1. Creative BioLabs A

21.3.1.1. Overview

21.3.1.2. Platform Type Portfolio

21.3.1.3. Key financials

21.3.1.4. Sales Footprint

21.3.1.5. SWOT Analysis

21.3.1.6. Strategy Overview

21.3.1.6.1. Marketing Strategy

21.3.1.6.2. Platform Type Strategy

21.3.1.6.3. Channel Strategy

21.3.2. Synbio Technologies

21.3.2.1. Overview

21.3.2.2. Platform Type Portfolio

21.3.2.3. Key financials

21.3.2.4. Sales Footprint

21.3.2.5. SWOT Analysis

21.3.2.6. Strategy Overview

21.3.2.6.1. Marketing Strategy

21.3.2.6.2. Platform Type Strategy

21.3.2.6.3. Channel Strategy

21.3.3. ProSci Incorporated

21.3.3.1. Overview

21.3.3.2. Platform Type Portfolio

21.3.3.3. Key financials

21.3.3.4. Sales Footprint

21.3.3.5. SWOT Analysis

21.3.3.6. Strategy Overview

21.3.3.6.1. Marketing Strategy

21.3.3.6.2. Platform Type Strategy

21.3.3.6.3. Channel Strategy

21.3.4. BioCat GmbH

21.3.4.1. Overview

21.3.4.2. Platform Type Portfolio

21.3.4.3. Key financials

21.3.4.4. Sales Footprint

21.3.4.5. SWOT Analysis

21.3.4.6. Strategy Overview

21.3.4.6.1. Marketing Strategy

21.3.4.6.2. Platform Type Strategy

21.3.4.6.3. Channel Strategy

21.3.5. Antibody Design Labs

21.3.5.1. Overview

21.3.5.2. Platform Type Portfolio

21.3.5.3. Key financials

21.3.5.4. Sales Footprint

21.3.5.5. SWOT Analysis

21.3.5.6. Strategy Overview

21.3.5.6.1. Marketing Strategy

21.3.5.6.2. Platform Type Strategy

21.3.5.6.3. Channel Strategy

21.3.6. GenScript

21.3.6.1. Overview

21.3.6.2. Platform Type Portfolio

21.3.6.3. Key financials

21.3.6.4. Sales Footprint

21.3.6.5. SWOT Analysis

21.3.6.6. Strategy Overview

21.3.6.6.1. Marketing Strategy

21.3.6.6.2. Platform Type Strategy

21.3.6.6.3. Channel Strategy

21.3.7. Oak BioSciences, Inc

21.3.7.1. Overview

21.3.7.2. Platform Type Portfolio

21.3.7.3. Key financials

21.3.7.4. Sales Footprint

21.3.7.5. SWOT Analysis

21.3.7.6. Strategy Overview

21.3.7.6.1. Marketing Strategy

21.3.7.6.2. Platform Type Strategy

21.3.7.6.3. Channel Strategy

21.3.8. Rockland Immunochemicals, Inc

21.3.8.1. Overview

21.3.8.2. Platform Type Portfolio

21.3.8.3. Key financials

21.3.8.4. Sales Footprint

21.3.8.5. SWOT Analysis

21.3.8.6. Strategy Overview

21.3.8.6.1. Marketing Strategy

21.3.8.6.2. Platform Type Strategy

21.3.8.6.3. Channel Strategy

21.3.9. Hybrigenics Services

21.3.9.1. Overview

21.3.9.2. Platform Type Portfolio

21.3.9.3. Key financials

21.3.9.4. Sales Footprint

21.3.9.5. SWOT Analysis

21.3.9.6. Strategy Overview

21.3.9.6.1. Marketing Strategy

21.3.9.6.2. Platform Type Strategy

21.3.9.6.3. Channel Strategy

21.3.10. NeoClone Biotechnology International LLC

21.3.10.1. Overview

21.3.10.2. Platform Type Portfolio

21.3.10.3. Key financials

21.3.10.4. Sales Footprint

21.3.10.5. SWOT Analysis

21.3.10.6. Strategy Overview

21.3.10.6.1. Marketing Strategy

21.3.10.6.2. Platform Type Strategy

21.3.10.6.3. Channel Strategy

21.3.11. Kaneka Eurogentec S.A

21.3.11.1. Overview

21.3.11.2. Platform Type Portfolio

21.3.11.3. Key financials

21.3.11.4. Sales Footprint

21.3.11.5. SWOT Analysis

21.3.11.6. Strategy Overview

21.3.11.6.1. Marketing Strategy

21.3.11.6.2. Platform Type Strategy

21.3.11.6.3. Channel Strategy

21.3.12. ProteoGenix

21.3.12.1. Overview

21.3.12.2. Platform Type Portfolio

21.3.12.3. Key financials

21.3.12.4. Sales Footprint

21.3.12.5. SWOT Analysis

21.3.12.6. Strategy Overview

21.3.12.6.1. Marketing Strategy

21.3.12.6.2. Platform Type Strategy

21.3.12.6.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

ページTOPに戻る

Table of Contents

Summary

Single Domain Antibody Platforms Market - Scope of Report

The latest publication by Persistence Market Research on the global single domain antibody platforms market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for single domain antibodies and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the single domain antibody platforms market. The insights and information presented in this persistence market research study can be leveraged by shareholders in the single domain antibody platforms market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the single domain antibody platforms market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the single domain antibody platforms market offers information divided into five important segments – platform type, animal source, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Platform Type

Multi-specific Single Domain Antibody
Bispecific Single Domain Antibody
Multivalent Single Domain Antibody
Mono-specific Single Domain Antibody
Animal Source

Camelids
Camels
Llamas
Alpacas
Sharks
Application

Diagnostic Development
Therapeutic Development
Research & Developmental Activities
End User

Diagnostic Laboratories
Clinical Laboratories
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for single domain antibodies over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the single domain antibody platforms market avail themselves of the growth opportunities in developed and emerging sectors?
Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the single domain antibody platforms market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the single domain antibody platforms market more accurate and reliable.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（抗生物薬）の最新刊レポート

Persistence Market Research社の抗生物薬分野での最新刊レポート

本レポートと同じKEY WORD（antibody）の最新刊レポート

よくあるご質問

Persistence Market Research社はどのような調査会社ですか?

パーシスタンスマーケットリサーチ（Persistence Market Research/PMR）は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

単一ドメイン抗体プラットフォームに関する市場調査。治療薬開発への高い応用が見込まれる

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（抗生物薬）の最新刊レポート

Persistence Market Research社の抗生物薬分野での最新刊レポート

本レポートと同じKEY WORD（antibody）の最新刊レポート

よくあるご質問

Persistence Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?